MA24401A1 - Procede pour la preparation de pyridines substitues et intemediaires utilisees a cette fin - Google Patents

Procede pour la preparation de pyridines substitues et intemediaires utilisees a cette fin

Info

Publication number: MA24401A1
Authority: MA; Morocco
Prior art keywords: intemedary; substituted; preparation; pyridines used; pyridines
Prior art date: 1996-11-14

Application number

MA24864A

Other languages

English (en)

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-11-14

Filing date

1997-11-11

Publication date

1998-07-01

1997-11-11 Application filed by Pfizer filed Critical Pfizer

1998-07-01 Publication of MA24401A1 publication Critical patent/MA24401A1/fr

Links

RQMWVVBHJMUJNZ-UHFFFAOYSA-N 4-chloropyridin-2-amine Chemical compound NC1=CC(Cl)=CC=N1 RQMWVVBHJMUJNZ-UHFFFAOYSA-N 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/73—Unsubstituted amino or imino radicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Diabetes (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Hematology (AREA)
Obesity (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Pyridine Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Plural Heterocyclic Compounds (AREA)

MA24864A 1996-11-14 1997-11-11 Procede pour la preparation de pyridines substitues et intemediaires utilisees a cette fin MA24401A1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US3088096P	1996-11-14	1996-11-14

Publications (1)

Publication Number	Publication Date
MA24401A1 true MA24401A1 (fr)	1998-07-01

Family

ID=21856496

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA24864A MA24401A1 (fr)	1996-11-14	1997-11-11	Procede pour la preparation de pyridines substitues et intemediaires utilisees a cette fin

Country Status (32)

Country	Link
US (1)	US6291489B1 (fr)
EP (1)	EP0938476B1 (fr)
JP (1)	JP3510635B2 (fr)
KR (1)	KR20000053314A (fr)
CN (1)	CN1237160A (fr)
AP (1)	AP805A (fr)
AR (1)	AR010584A1 (fr)
AT (1)	ATE319687T1 (fr)
AU (1)	AU4634697A (fr)
BG (1)	BG103393A (fr)
BR (1)	BR9712951A (fr)
CA (1)	CA2270386C (fr)
CO (1)	CO4930261A1 (fr)
DE (1)	DE69735433D1 (fr)
EA (1)	EA199900375A1 (fr)
GT (1)	GT199700118A (fr)
HR (1)	HRP970612A2 (fr)
ID (1)	ID18898A (fr)
IL (1)	IL129688A0 (fr)
IS (1)	IS5029A (fr)
MA (1)	MA24401A1 (fr)
MY (1)	MY132507A (fr)
NO (1)	NO992296L (fr)
OA (1)	OA11044A (fr)
PA (1)	PA8441401A1 (fr)
PE (1)	PE10299A1 (fr)
TN (1)	TNSN97172A1 (fr)
TR (1)	TR199901063T2 (fr)
UY (1)	UY24774A1 (fr)
WO (1)	WO1998021184A1 (fr)
YU (1)	YU22099A (fr)
ZA (1)	ZA9710186B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1999052892A2 (fr) *	1998-04-08	1999-10-21	Novartis Ag	Nouveaux herbicides
US6090942A (en) *	1998-10-15	2000-07-18	Pfizer Inc.	Process and intermediates for a β3 -adrenergic receptor agonist
AU2571300A (en) *	1999-02-16	2000-09-04	Kaneka Corporation	Substituted acetylpyridine derivatives and process for the preparation of intermediates for optically active beta3 agonist by the use of the same
US6455734B1 (en) *	2000-08-09	2002-09-24	Magnesium Diagnostics, Inc.	Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states
DE60015036T2 (de) *	1999-07-23	2006-03-02	Pfizer Products Inc., Groton	Zwischenprodukte und ein Verfahren zur Herstellung von beta3-Adrenergischer Rezeptor-Agoniste
US20040265991A1 (en) *	2001-10-17	2004-12-30	Naoaki Taoka	Process for preparation of (s)-alpha-halomethylpyridine-methanol derivatives
WO2003072547A1 (fr)	2002-02-27	2003-09-04	Pfizer Products Inc.	Procedes et intermediaires utiles dans la preparation d'agonistes du recepteur $g(b)3 adrenergique
US6864268B2 (en)	2002-02-27	2005-03-08	Pfizer Inc.	β3 adrenergic receptor agonists
WO2003072573A1 (fr) *	2002-02-27	2003-09-04	Pfizer Products Inc.	Formes cristallines de (r)-2-(2-(4-oxazol-4-yl-phenoxy)-ethylamino)-1-pyridin-3-yl-ethanol
EP1424079A1 (fr) *	2002-11-27	2004-06-02	Boehringer Ingelheim International GmbH	Combinaison d'un agoniste du beta-3-récepteur et d'un inhibiteur de recaptage de sérotonine et/ou norépinéphrine
RU2313524C2 (ru)	2003-05-09	2007-12-27	Ф.Хоффманн-Ля Рош Аг	МИТИЛИНДОЛЫ И МЕТИЛПИРРОЛОПИРИДИНЫ, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, ОБЛАДАЮЩАЯ АКТИВНОСТЬЮ α-1-АДРЕНЕРГИЧЕСКИХ АГОНИСТОВ
GB2431927B (en)	2005-11-04	2010-03-17	Amira Pharmaceuticals Inc	5-Lipoxygenase-activating protein (FLAP) inhibitors
US7977359B2 (en)	2005-11-04	2011-07-12	Amira Pharmaceuticals, Inc.	5-lipdxygenase-activating protein (FLAP) inhibitors
US8399666B2 (en)	2005-11-04	2013-03-19	Panmira Pharmaceuticals, Llc	5-lipoxygenase-activating protein (FLAP) inhibitors
MX2010012814A (es)	2008-05-23	2010-12-20	Amira Pharmaceuticals Inc	Inhibidor de proteina activadora de 5-lipoxigenasa.
US8546431B2 (en)	2008-10-01	2013-10-01	Panmira Pharmaceuticals, Llc	5-lipoxygenase-activating protein (FLAP) inhibitors

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4358455A (en)	1980-12-23	1982-11-09	Merck & Co., Inc.	Aralkylamindethanol heterocyclic compounds
US5019578A (en)	1987-11-27	1991-05-28	Merck & Co., Inc.	β-adrenergic agonists
BR9406823A (pt) *	1993-06-14	1996-03-26	Pfizer	Aminas secundárias e agentes anti-diabéticos e antiobesidade
IL113410A (en) *	1994-04-26	1999-11-30	Merck & Co Inc	Substituted sulfonamides having an asymmetric center and pharmaceutical compositions containing them
WO1996035670A1 (fr)	1995-05-10	1996-11-14	Pfizer Inc.	AGONISTES DU RECEPTEUR β-ADRENERGIQUE
US5977124A (en) *	1995-05-10	1999-11-02	Pfizer Inc.	β-adrenergic agonists

1997
- 1997-11-03 WO PCT/IB1997/001367 patent/WO1998021184A1/fr not_active Ceased
- 1997-11-03 EA EA199900375A patent/EA199900375A1/ru unknown
- 1997-11-03 JP JP52233298A patent/JP3510635B2/ja not_active Expired - Fee Related
- 1997-11-03 EP EP97945047A patent/EP0938476B1/fr not_active Expired - Lifetime
- 1997-11-03 TR TR1999/01063T patent/TR199901063T2/xx unknown
- 1997-11-03 CA CA002270386A patent/CA2270386C/fr not_active Expired - Fee Related
- 1997-11-03 YU YU22099A patent/YU22099A/sh unknown
- 1997-11-03 AU AU46346/97A patent/AU4634697A/en not_active Abandoned
- 1997-11-03 AT AT97945047T patent/ATE319687T1/de not_active IP Right Cessation
- 1997-11-03 CN CN97199663A patent/CN1237160A/zh active Pending
- 1997-11-03 US US09/297,694 patent/US6291489B1/en not_active Expired - Fee Related
- 1997-11-03 BR BR9712951-8A patent/BR9712951A/pt not_active Application Discontinuation
- 1997-11-03 KR KR1019990704312A patent/KR20000053314A/ko not_active Abandoned
- 1997-11-03 DE DE69735433T patent/DE69735433D1/de not_active Expired - Lifetime
- 1997-11-03 IL IL12968897A patent/IL129688A0/xx unknown
- 1997-11-11 MA MA24864A patent/MA24401A1/fr unknown
- 1997-11-11 GT GT199700118A patent/GT199700118A/es unknown
- 1997-11-11 PE PE1997001004A patent/PE10299A1/es not_active Application Discontinuation
- 1997-11-12 UY UY24774A patent/UY24774A1/es unknown
- 1997-11-12 MY MYPI97005396A patent/MY132507A/en unknown
- 1997-11-12 ZA ZA9710186A patent/ZA9710186B/xx unknown
- 1997-11-12 AR ARP970105279A patent/AR010584A1/es not_active Application Discontinuation
- 1997-11-12 PA PA19978441401A patent/PA8441401A1/es unknown
- 1997-11-12 TN TNTNSN97172A patent/TNSN97172A1/fr unknown
- 1997-11-13 CO CO97066763A patent/CO4930261A1/es unknown
- 1997-11-13 AP APAP/P/1997/001147A patent/AP805A/en active
- 1997-11-13 ID IDP973662A patent/ID18898A/id unknown
- 1997-11-13 HR HR60/030,880A patent/HRP970612A2/hr not_active Application Discontinuation
1999
- 1999-04-16 IS IS5029A patent/IS5029A/is unknown
- 1999-05-07 OA OA9900096A patent/OA11044A/en unknown
- 1999-05-11 BG BG103393A patent/BG103393A/xx unknown
- 1999-05-12 NO NO992296A patent/NO992296L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
AU4634697A (en)	1998-06-03
MY132507A (en)	2007-10-31
US6291489B1 (en)	2001-09-18
CN1237160A (zh)	1999-12-01
JP2000504347A (ja)	2000-04-11
ID18898A (id)	1998-05-20
PA8441401A1 (es)	2000-05-24
NO992296D0 (no)	1999-05-12
IL129688A0 (en)	2000-02-29
AP805A (en)	2000-01-28
IS5029A (is)	1999-04-16
ATE319687T1 (de)	2006-03-15
CO4930261A1 (es)	2000-06-27
DE69735433D1 (de)	2006-05-04
EA199900375A1 (ru)	1999-12-29
CA2270386C (fr)	2004-08-03
HRP970612A2 (en)	1998-08-31
BR9712951A (pt)	1999-12-07
OA11044A (en)	2002-02-20
AP9701147A0 (en)	1998-01-31
JP3510635B2 (ja)	2004-03-29
EP0938476A1 (fr)	1999-09-01
YU22099A (sh)	2001-09-28
KR20000053314A (ko)	2000-08-25
BG103393A (en)	2000-07-31
ZA9710186B (en)	1999-05-12
CA2270386A1 (fr)	1998-05-22
AR010584A1 (es)	2000-06-28
TR199901063T2 (xx)	1999-08-23
TNSN97172A1 (fr)	2005-03-15
EP0938476B1 (fr)	2006-03-08
GT199700118A (es)	1999-05-05
PE10299A1 (es)	1999-02-10
UY24774A1 (es)	1998-05-05
NO992296L (no)	1999-05-12
WO1998021184A1 (fr)	1998-05-22

Publication	Publication Date	Title
MA24401A1 (fr)	1998-07-01	Procede pour la preparation de pyridines substitues et intemediaires utilisees a cette fin
MA23611A1 (fr)	1996-04-01	Procede pour la synthese de sulfoxydes substitues
MA24426A1 (fr)	1998-07-01	Procede pour la preparation de nouveaux composes
EP0738424A4 (fr)	1998-04-29	Procede et structure de passivation pour circuit integre
MA21962A1 (fr)	1991-04-01	Procede pour la preparation d'inhibiteurs de proteass retrovirales .
MA20880A1 (fr)	1987-10-01	Procede pour la preparation de derives de thienoimidazole substitues
MA21983A1 (fr)	1991-07-01	Procede pour la preparation de derives de quinolone .
FR2654332B1 (fr)	1997-11-21	Appareillage pour stomie.
FR2509300B1 (fr)	1986-02-21	Derives d'azetidinone et procede pour leur preparation
RO93218A (fr)	1987-12-31	Procede pour la preparation des derives de 2-oxyndole
FR2687687B1 (fr)	1997-05-23	Procede pour mesurer la taille de fragments d'adn.
RO96413A (fr)	1989-03-30	Procede pour la preparation des derives de thoadiazole
MA24319A1 (fr)	1998-04-01	Procedes et intermediaires pour la preparation de derives de chromanol substitues
MA23900A1 (fr)	1996-12-31	Procede pour la preparation de compositions antiretrovirale
MA21984A1 (fr)	1991-07-01	Procede pour la preparation de derives de quilinone .
FR2559771B1 (fr)	1986-12-26	Derives de la 3-pyrrolidinopropiophenone et procede pour leur preparation
FR2663173B1 (fr)	1995-09-22	Circuit d'attenuation et procede d'etalonnage pour ce circuit.
FI904680A7 (fi)	1991-03-27	Menetelmä ja laite folioiden "kylmäsyvävetämiseksi"
MA24245A1 (fr)	1998-04-01	Procede pour la preparation de nouveaux composes sulfonylures
FR2555578B1 (fr)	1990-06-01	Procede de preparation de derives d'azetidinone
MA24078A1 (fr)	1997-10-01	Procede pour l'utilisation de derives de tetrahydroisoquinoleine
FR2731365B1 (fr)	1999-02-19	Tensioactif glycolipidique et procede pour sa preparation
FR2551079B1 (fr)	1988-02-05	Compositions perfectionnees pour la dissolution de metaux et procede de dissolution
FR2574792B1 (fr)	1987-12-24	Procede pour la preparation de derives de pyrrolidine
FR2564460B1 (fr)	1987-07-17	Methyl 2-(2-hydroperoxy-2-propyl)naphtalene-6-carboxylate et procede pour sa preparation